Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mira Baspayeva
Observed names:
M Baspayeva,
M.B. Baspayeva,
Mira B. Baspayeva
Institution:
West Kazakhstan Marat Ospanov State Medical University
Observed institution:
West Kazakhstan Marat Ospanov State Medical University
ORCID:
0000-0001-6361-4841
Observed ORCID:
0000-0001-6361-4841
OpenAlex ID:
A5000002845
Early Diagnosis of Chemotherapy-Linked Cardiotoxicity in Breast Cancer Patients Using Conventional Biomarker Panel: A Prospective Study Protocol
2022
·
Saule Balmagambetova
, Zhenisgul Tlegenova
, et al.
·
Diagnostics
·
14
PDF
Stratifying breast cancer patients by baseline risk of cardiotoxic complications linked to chemotherapy
2023
·
Zhenisgul Tlegenova
, Saule Balmagambetova
, et al.
·
Journal of Clinical Medicine of Kazakhstan
·
5
PDF
A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan
2022
·
Saule Balmagambetova
, Zhenisgul Tlegenova
, et al.
·
Journal of Clinical Medicine of Kazakhstan
·
5
PDF
Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan
2023
·
Zhenisgul Tlegenova
, Saule Balmagambetova
, et al.
·
Diagnostics
·
4
PDF
Three-year follow-up of anthracycline-induced cardiotoxicity risk in breast cancer patients using the HFA-ICOS score
2025
·
A Amanova
, Z H Tlegenova
, et al.
·
European Heart Journal Supplements
·
1
Cardiotoxicity of Anthracycline-based Chemotherapy in Breast Cancer Patients: A Case Series
2024
·
Zhenisgul Sh. Tlegenova
, Saule K. Balmagambetova
, et al.
·
Медицинский журнал Западного Казахстана
·
1
PDF
Prospective External Validation of the HFA-ICOS Baseline Cardiovascular Risk Classification in Women with Breast Cancer Receiving Anthracycline-Containing Therapy in a Central Asian Cohort
2026
·
Aiganym Amanova
, Bekbolat Zholdin
, et al.
·
Diagnostics
A structured clinical decision support tool for cardiovascular risk stratification and longitudinal monitoring during anthracycline and HER2-targeted therapy
2026
·
Y Kulmukhanov
, Z H Tlegenova
, et al.
·
European Heart Journal Supplements
PDF
Risk-stratified changes in left atrial strain during chemotherapy: preliminary data
2026
·
B Zholdin
, A Amanova
, et al.
·
European Heart Journal Supplements
Right ventricular strain dynamics during anthracycline therapy in breast cancer patients stratified by cardiotoxicity risk: preliminary results
2026
·
Z H Tlegenova
, A Amanova
, et al.
·
European Heart Journal Supplements
Endothelial function trajectories during anthracycline chemotherapy by baseline cardiovascular risk: a prospective three-time point study
2026
·
A Amanova
, Z H Tlegenova
, et al.
·
European Heart Journal Supplements
Show more works
View as search
Works count:
12
Citation count:
30
H-index:
4
I10-index:
1
Year
Topic
Type